Literature DB >> 21737410

State disparities in colorectal cancer mortality patterns in the United States.

Deepa Naishadham1, Iris Lansdorp-Vogelaar, Rebecca Siegel, Vilma Cokkinides, Ahmedin Jemal.   

Abstract

BACKGROUND: Colorectal cancer (CRC) mortality rates have been decreasing for many decades in the United States, with the decrease accelerating in the most recent time period. The extent to which this decrease varies across states and its influence on the geographic patterns of rates is unknown.
METHODS: We analyzed the temporal trend in age-standardized CRC death rates for each state from 1990 to 2007 using joinpoint regression. We also examined the change in death rates between 1990-1994 and 2003-2007 using rate ratios with 95% confidence intervals and illustrated the change in pattern using maps. The relationship between the change in mortality rates and CRC screening rates for 2004 by state was examined using Pearson's correlation.
RESULTS: CRC mortality rates significantly decreased in all states except Mississippi between 1990 and 2007 based on the joinpoint model. The decrease in death rates between 1990-1994 and 2003-2007 ranged from 9% in Alabama to greater than 33% in Massachusetts, Rhode Island, New York, and Alaska; Mississippi and Wyoming showed no significant decrease. Generally, the northeastern states showed the largest decreases, whereas southern states showed the smallest decreases. The highest CRC mortality rates shifted from the northeastern states during 1990 to 1994 to the southern states along the Appalachian corridor during 2003 to 2007. The decrease in CRC mortality rates by state correlated strongly with uptake of screening (r = -0.65, P < 0.0001).
CONCLUSIONS: Progress in reducing CRC mortality varies across states, with the Northeast showing the most progress and the South showing the least progress. IMPACT: These findings highlight the need for wider dissemination of CRC screening. ©2011 AACR

Entities:  

Mesh:

Year:  2011        PMID: 21737410     DOI: 10.1158/1055-9965.EPI-11-0250

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  46 in total

1.  Patient activation increases colorectal cancer screening rates: a randomized trial among low-income minority patients.

Authors:  Mira L Katz; James L Fisher; Kelly Fleming; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-08       Impact factor: 4.254

2.  Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.

Authors:  Kai Huang; Rongfa Yuan; Kai Wang; Junwen Hu; Zixi Huang; Chen Yan; Wei Shen; Jianghua Shao
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

3.  State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences.

Authors:  Iris Lansdorp-Vogelaar; S Lucas Goede; Jiemin Ma; Wu Xiau-Cheng; Karen Pawlish; Marjolein van Ballegooijen; Ahmedin Jemal
Journal:  Cancer       Date:  2015-07-06       Impact factor: 6.860

4.  Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.

Authors:  Mehdi Manoochehri; Ashraf Karbasi; Mojgan Bandehpour; Bahram Kazemi
Journal:  Pathol Oncol Res       Date:  2013-10-14       Impact factor: 3.201

5.  Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.

Authors:  Alex van der Steen; Amy B Knudsen; Frank van Hees; Gailya P Walter; Franklin G Berger; Virginie G Daguise; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Health Serv Res       Date:  2014-10-16       Impact factor: 3.402

6.  Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data.

Authors:  Melinda M Davis; Stephanie Renfro; Robyn Pham; Kristen Hassmiller Lich; Jackilen Shannon; Gloria D Coronado; Stephanie B Wheeler
Journal:  Prev Med       Date:  2017-05-13       Impact factor: 4.018

7.  Adenocarcinoma of the proximal rectum and synchronous non-Hodgkin's lymphoma.

Authors:  Johnny Yap; Andrew Soh
Journal:  J Gastrointest Oncol       Date:  2013-03

8.  Patient-provider discussions about colorectal cancer screening: who initiates elements of informed decision making?

Authors:  Mira L Katz; Ben Broder-Oldach; James L Fisher; Justin King; Kathy Eubanks; Kelly Fleming; Electra D Paskett
Journal:  J Gen Intern Med       Date:  2012-04-05       Impact factor: 5.128

9.  A geographic information system-based method for estimating cancer rates in non-census defined geographical areas.

Authors:  Vincent L Freeman; Emma E Boylan; Oksana Pugach; Sara L Mclafferty; Katherine Y Tossas-Milligan; Karriem S Watson; Robert A Winn
Journal:  Cancer Causes Control       Date:  2017-08-20       Impact factor: 2.506

10.  Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region.

Authors:  Whitney Guerrero; Amy Wise; Garrett Lim; Lei Dong; Jim Wan; Jeremiah Deneve; Evan Glazer; Paxton Dickson; R Scott Daugherty; Martin Fleming; David Shibata
Journal:  J Gastrointest Surg       Date:  2017-11-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.